Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas

Histopathology

Volumn 45, Issue 6, 2004, Pages 603-611

  Hemmerlein, B ^a,b   Galuschka, L ^a   Putzer, N ^a   Zischkau, S ^a   Heuser, M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

COX 2; Renal cell carcinoma; Tumour microvessel; VEGF

Indexed keywords

CD31 ANTIGEN; CYCLOOXYGENASE 2; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL AGGREGATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DENSITY; DOWN REGULATION; ENDOTHELIUM; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MACROPHAGE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR NECROSIS; TUMOR REGRESSION; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, RENAL CELL; CELL HYPOXIA; CELL LINE, TUMOR; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11144256492     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.02019.x     Document Type: Article

References (21)

1. Oshima M, Dinchuk JE, Kargman SL et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87; 803-809.
2. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107; 1183-1188.
3. van Rees BP, Saukkonen K, Ristimaki A et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 2002; 196; 171-179.
4. Madaan S, Abel PD, Chaudhary KS et al. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int. 2000; 86; 736-741.
5. Denkert C, Kobel M, Berger S et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res. 2001; 61; 303-308.
6. Joki T, Heese O, Nikas DC et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000; 60; 4926-4931.
7. Fujita H, Koshida K, Keller ET et al. Cyclooxygenase-2 promotes prostate cancer progression. Prostate 2002; 53; 232-240.
8. Kamijo T, Sato T, Nagatomi Y, Kitamura T. Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines. Int. J. Urol. 2001; 8; S35-S39.
9. Fossilen E. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann. Clin. Lab. Sci. 2001; 31; 325-348.
10. Li M, Wu X, Xu XC. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin. Cancer Res. 2001; 7; 1010-1016.
11. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res. 2000; 60; 4629-4637.
12. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 1997; 272; 601-608.
13. Yang X, Sheares KK, Davie N et al. Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 2002; 27; 688-696.
14. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 1999; 79; 991-995.
15. Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch. 2001; 439; 645-652.
16. Hemmerlein B, Markus A, Wehner M, Kugler A, Zschunke F, Radzun HJ. Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas. Cancer Immunol. Immunother. 2000; 49; 485-492.
17. Imhof A, Heinzer I. Continuous monitoring of oxygen concentrations in several systems for cultivation of anaerobic bacteria. J. Clin. Microbiol. 1996; 34; 1646-1648.
18. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998; 58; 4997-5001.
19. Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res. 2000; 60; 4044-4048.
20. Abd-El-Aleem SA, Ferguson MW, Appleton I, Bhowmick A, McCollum CN, Ireland GW. Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J. Pathol. 2001; 195; 616-623.
21. Jones MK, Szabo IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 2002; 16; 264-266.